Marstacimab approved to treat patients aged 12 years and above (weighing at least 35 kg) with haemophilia A or B

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the medicine marstacimab (Hympavzi) to prevent or reduce bleeding in patients 12 years of age and older weighing at least 35 kg with haemophilia…

Continue ReadingMarstacimab approved to treat patients aged 12 years and above (weighing at least 35 kg) with haemophilia A or B

Beckman Coulter Life Sciences transforms purification with the launch of the OptiMATE Gradient Maker

Beckman Coulter Life Sciences, a Danaher company and a global leader in laboratory automation and innovation, announces the launch of the OptiMATE Gradient Maker, a groundbreaking instrument designed to automate…

Continue ReadingBeckman Coulter Life Sciences transforms purification with the launch of the OptiMATE Gradient Maker